India

Delhi High Court Dismisses Plea for Mandatory Disclosure of Drug Side Effects by Doctors

The Delhi High Court has dismissed a plea seeking a directive requiring medical professionals to explicitly state all potential risks and side effects of medicines or pharmaceutical drugs when administered to a patient. The division bench, consisting of Acting Chief Justice Manmohan Singh and Justice Manmeet Pritam Singh Arora, referred to the Drugs and Cosmetics Act of 1945, which mandates drug manufacturers or their agents to provide package inserts detailing the side effects to consumers and pharmacies.

The bench stated that since the legislature has assigned this responsibility to manufacturers and pharmacists, the court cannot issue the directions sought in the Public Interest Litigation (PIL) as it would be tantamount to judicial overreach.

PIL Rejected

The bench highlighted that the petitioner did not dispute the adequacy of the information provided by manufacturers through inserts accompanying medicines sold by registered pharmacists. However, the petitioner contended that if doctors included this information alongside their prescriptions, patients and caregivers could make informed choices with valid consent. The court noted that the legislature had intentionally placed this duty on manufacturers and pharmacists, leaving no grounds for the court to issue the directions requested in the PIL. Since the PIL acknowledged that there was no regulatory gap, the court concluded that the requested directions could not be granted. Consequently, the PIL and associated applications were dismissed.

Also read: Lok Sabha Elections Phase 5: 56.68% Voter Turnout by 5 PM, West Bengal Tops with 73%

Petitioner’s Argument

The PIL was filed by Jacob Vadakanchery, who argued that medicines can have severe side effects and that patients have a right to make informed choices. He asserted that it should be mandatory for prescribing doctors to inform patients about these side effects. Vadakanchery claimed that prescribing medicine without detailing potential side effects does not constitute obtaining valid consent from the patient. He urged for the responsibility to shift from manufacturers and pharmacists to medical practitioners to ensure patients are properly informed.

Kavya Bhatt

Recent Posts

PM Modi Interacts With Group Captain Shubhanshu Shukla Aboard The ISS

PM Narendra Modi interacted with Group Captain Shubhanshu Shukla, the first Indian to reach the…

19 mins ago

Gautam Adani, Family Participate In Puri Rath Yatra; Launch Massive ‘Prasad Seva’ Initiative

Gautam Adani, along with his wife Priti Adani and son Karan Adani, joined thousands of…

58 mins ago

PM Modi, Leaders Pay Tribute To Former PM PV Narasimha Rao On Birth Anniversary

PM Narendra Modi on Saturday paid tribute to former Prime Minister PV Narasimha Rao on…

1 hour ago

Gautam Adani Hails Divine Experience At Rath Yatra; Praises Odisha’s Graceful Management

Gautam Adani conveyed profound spiritual emotions after witnessing the revered Rath Yatra of Lord Jagannath…

1 hour ago

Punjab’s Litchis Reach Middle East Markets In Boost To India’s Fruit Exports

In a step towards diversifying India’s horticultural exports, Punjab has successfully shipped its first consignment…

2 hours ago

Dalal Street Sees Strong Activity Of IPOs In June As Market Sentiment Improves

India’s primary market experienced a surge in activity in June 2025 as investor sentiment toward…

3 hours ago